// App-Quantinova.ai

BSH2020‐PO‐094 : Investigating the clinical utility of a next generation sequencing B‐cell clonality assay. case study: identification ighv4‐34 rearrangement and assess its prognostic value in hairy cell leukaemia

Researchers

Presenter

  • K. Quevedo

Principal Investigators

  • P. Wright

  • A. Timbs

  • E. Wilson

  • D. Bruce

  • T. Cranston

  • H. Dreau

  • A. Hamblin

Medical Centers

  • Molecular Haematology/Oxford Regional Genetics Laboratories

  • Hematology

  • Oxford University Hospitals NHS Trust, Oxford,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hairy cell leukemia

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Immunoglobulin heavy-chain variable region gene

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved